Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

117
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
117
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biopsychosocial and demographic predictors of functional brain network specialization and segregation across the adult lifespan.

Neurobiology of aging·2026
Same author

Double-tube end ileostomy: an alternative to classical defunctioning stoma in rectal surgery.

Techniques in coloproctology·2025
Same author

Computed tomography (CT) structured reporting generation based on the intelligent assisted diagnosis system for rectal cancer staging and evaluation of its clinical application.

Clinical radiology·2025
Same author

Congenital absence of the pulmonary valve.

BMJ case reports·2025
Same author

[Characteristics of cardiovascular and cerebrovascular diseases in patients with primary aldosteronism: a propensity score matching study].

Zhonghua nei ke za zhi·2025
Same author

Technical Aspects of a National Service for Paediatric Pelvic Brachytherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same journal

Research Trends in Physical Activity and Breast Cancer: A 25-Year Bibliometric Analysis (2000-2025).

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Concordance Between Planned and Delivered treatment for Head and Neck Cancer Patients Treated With Curative Intent: A Real-World Comparison of Under 70-year-olds With 70-year-olds and Over.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

A Novel Technique for Pain Management to Deliver a Course of Palliative Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Broad-Spectrum Antibiotics are Associated with worse Survival After Radical Treatment for Glioblastoma Multiforme: A Multicentre Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Exploring the Need for Plan Adaptation in Robustly Optimised Head and Neck Intensity Modulated Proton Therapy: A Dosimetric Perspective From Initial Institutional Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Lifting the Lid on Best Practice in a Case of Oligometastatic Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
See all related articles

Related Experiment Video

Updated: Nov 28, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.8K

Paediatric Molecular Radiotherapy: Challenges and Opportunities.

M D Aldridge1, C Peet2, S Wan3

  • 1Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK; Department of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|November 28, 2020
PubMed
Summary
This summary is machine-generated.

Paediatric molecular radiotherapy (pMRT) shows promise for treating cancers like thyroid cancer and neuroblastoma. Overcoming challenges in accessibility and research funding is key to unlocking its full potential for improved patient outcomes.

Keywords:
clinical trialsdifferentiated thyroid cancerdosimetryneuroblastomapaediatric molecular radiotherapyradionuclide therapy

More Related Videos

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.7K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.8K

Related Experiment Videos

Last Updated: Nov 28, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.7K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.8K

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiotherapy

Background:

  • Paediatric molecular radiotherapy (pMRT) is a precision therapy primarily used for differentiated thyroid cancer and neuroblastoma.
  • Its unique mechanism and safety profile offer advantages over conventional treatments.
  • Despite its potential, pMRT faces challenges in accessibility and research investment.

Purpose of the Study:

  • To provide an overview of the current status of paediatric molecular radiotherapy (pMRT).
  • To identify barriers hindering the progress and wider adoption of pMRT.
  • To explore strategies for overcoming these obstacles and advancing pMRT applications.

Main Methods:

  • Review of current clinical applications and research landscape of pMRT.
  • Analysis of challenges including limited specialized centers, accessibility issues, and suboptimal research funding.
  • Discussion of emerging opportunities, increased funding, and new clinical trials.

Main Results:

  • pMRT is a safe and effective biomarker-driven therapy for specific paediatric cancers.
  • Significant barriers include limited treatment centers, geographical disparities, and historical underfunding of research.
  • Growing interest and new research initiatives are emerging, with potential for curative applications.

Conclusions:

  • Paediatric molecular radiotherapy (pMRT) holds significant promise but requires optimized therapeutic strategies and personalized delivery.
  • Addressing accessibility and increasing research investment are crucial for expanding its use.
  • New clinical trials and technical advancements are paving the way for pMRT to transition towards curative protocols.